research Androgen Receptor Genetic Variant Predicts COVID-19 Disease Severity: A Prospective Longitudinal Study of Hospitalized COVID-19 Male Patients
A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.
Search
for
Sort by
Research
600-630 / 1000+ results 
research Rash Morphology as a Predictor of COVID-19 Severity: A Systematic Review of the Cutaneous Manifestations of COVID-19
Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.
research ACE1 rs1799752 Polymorphism Is Not Associated With Long-COVID Symptomatology In Previously Hospitalized COVID-19 Survivors
The ACE1 gene variant doesn't affect long-COVID symptoms.
research Role of ACE2 Polymorphism in COVID-19: Impact of Age
Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.
research Proxalutamide Improves Inflammatory, Immunologic, and Thrombogenic Markers in Mild-to-Moderate COVID-19 Males and Females: An Exploratory Analysis of a Randomized, Double-Blinded, Placebo-Controlled Trial Early Antiandrogen Therapy with Proxalutamide
Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.
research Clinical Course of Alopecia After COVID-19
A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.
research 5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double-Blind Placebo-Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men
5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.
research Protective Trend of Anti-Androgen Therapy During the COVID-19 Pandemic: A Meta-Analysis
Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.
research Androgenetic Alopecia in Women and Men Is Not Related to COVID-19 Infection Severity: A Prospective Cohort Study of Hospitalized COVID-19 Patients
Hair loss doesn't affect COVID-19 severity.
research Tofacitinib Treatment in Patients With Active COVID-19 Infection
Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.
research The Effects of Changing Lifestyle and Daily Behaviors in the First Months of COVID-19 Outbreak on Dermatological Diseases: Retrospective Cross-Sectional Observational Study
Lifestyle changes during the early COVID-19 outbreak led to more cases of acne and other skin conditions, but fewer cases of rosacea and skin infections.
research Comment on 'Androgens and Women: COVID-19 Outcomes in Women with Acne Vulgaris, Polycystic Ovarian Syndrome, and Hirsutism'
Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.
research Letter to the Editor on COVID-19 Infection in Men on Testosterone Replacement Therapy
The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.
research Knowledge, Attitude, and Practice Regarding COVID-19 Skin Manifestations Among Doctors Working at Khartoum Dermatology and Venereology Teaching Hospital, 2021
Many doctors lack knowledge about COVID-19 skin symptoms and need better education and guidelines.
research The Gabrin Sign's Potential for Identifying High-Risk Patients for COVID-19 With Androgenic Alopecia
The Gabrin sign may help identify COVID-19 patients at high risk who also have hair loss due to male hormones.
research The Role of Neurorehabilitation in Post-COVID-19 Syndrome
Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.
research Evidence Regarding the Use of the Monoclonal Antibody Tocilizumab as a Therapy for COVID-19
Tocilizumab might be an effective treatment for COVID-19.
research Profile and Clinical Character of COVID-19 Patients at Zahirah Hospital, South Jakarta
Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.
research Profile and Clinical Character of COVID-19 Patients at Zahirah Hospital, South Jakarta
Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.
research Free Testosterone Levels in Patients with COVID-19 and Its Association with Disease Severity
People with lower levels of free testosterone tend to have worse COVID-19 outcomes.
research Blood Group O and Post-COVID-19 Syndrome
People with blood group O may have a higher risk of developing post-COVID-19 syndrome.
research Immune System Response to the COVID-19 Virus and Third Boosters
Third booster shots enhance the immune system's response to the COVID-19 virus.
research Cutaneous T-Cell Lymphoma Outcomes During COVID-19
CTCL patients can safely continue treatment during COVID-19 with proper safety measures.
research Delivering Care for the Underserved During COVID-19 Through Real-Time Teledermatology: A Cross-Sectional Review of Patients at a Student-Run Free Clinic in Dallas
The study evaluated how alopecia areata severity relates to its psychosocial effects on patients.
research Egyptian Traditional Herbal Medicine Candidate Adiantum Capillus-Veneris Linn. as a Symptomatic Treatment for COVID-19: A Review of Its Mechanisms, Pros and Cons
Maidenhair fern might help with COVID-19 symptoms, but it needs more testing.
research Whole Plant Adiantum Capillus-Veneris Linn Extract as an Anti-COVID-19 Therapy
Maidenhair fern extract might help treat COVID-19 symptoms, but more research is needed.
research A Rare Case of Constrictive Pericarditis with Co-Existing Positive COVID-19: Probable Autoimmune or Immunoglobulin Related Disease
An 80-year-old man with COVID-19 also had constrictive pericarditis, possibly due to an autoimmune or immunoglobulin related disease, and improved after surgery.
research Study of Pediatric Dermatology Consultations During COVID-19 Lockdown
Most child skin problems during the COVID-19 lockdown were not emergencies and could have been handled by teleconsultation.
research Adiantum Capillus-Veneris Linn (Maidenhair Fern) Extract-Based Drug as a Symptomatic Treatment for COVID-19
Maidenhair fern extract may help treat COVID-19 symptoms.